Chemicals & Advanced Materials Global On demand · 24-48h

Global Cannabidiol (CBD) Distillate Market Strategic Research Report

Global Cannabidiol (CBD) Distillate Market Strategic Researc…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Cannabidiol (CBD) Distillate Market
$2952025
5.3%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Full Spectrum, Broad Spectrum

By Application: Dietary Supplements, Food and Beverages, E-cigarettes, Cosmetics, Pharmaceuticals

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Kemin, Pharma Works LLC (CanniLabs), SWISS ORGANIC PARTNERS AG, KND Labs, Sequoya, Eastern Spectrum Group, Alponics SA, Siam Herbal Tech, GVB Biopharma, Mile High Labs, EcoGen Biosciences, Ilesol Pharmaceuticals, Red Mesa Science & Refining, LLC, WeeDutch, Essentia Pura, Blue Sky Hemp Ventures, Verus Extracts

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 143 pages
Market size 2025
$295
Million USD
Forecast CAGR
5.3%
2025-2032
Forecast 2032
$423.5
Projected
区域
5
Asia Pacific · Latin America · MEA · Europe · North America

概述

Scope of the Report

The global Cannabidiol (CBD) Distillate market size is predicted to grow from US$ 295 million in 2025 to US$ 421 million in 2032; it is expected to grow at a CAGR of 5.3% from 2026 to 2032.

CBD distillate is a highly purified form of cannabidiol that's been refined to remove impurities, specifically THC. That concentrated oil can then be used or combined with a full-spectrum CBD for an even more potent, impactful blend.CBD Distillate is a reduced version of the entire hemp plant with 50%-70% CBD content. This leaves room for the remaining vitamins, terpenes, fatty acids and other cannabinoids meaning it has the same natural balance of chemicals as the Hemp plant itself.In short, both CBD isolate and CBD distillate are processed to have negligible amounts of THC. The difference is that CBD isolate is at least 99% CBD with only trace amounts of other substances (resulting in a notable limitation of biological benefits), while CBD distillate averages 50-70% CBD, coupled with 30-50% more natural cannabinoid compounds which work synergistically to aid and enhance what would otherwise be a restriction on potential health benefits.

Global key Cannabidiol (CBD) Distillate players cover Kemin, Pharma Works LLC (CanniLabs), SWISS ORGANIC PARTNERS AG, KND Labs, Sequoya, etc.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Cannabidiol (CBD) Distillate market?

What factors are driving Cannabidiol (CBD) Distillate market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Cannabidiol (CBD) Distillate market opportunities vary by end market size?

How does Cannabidiol (CBD) Distillate break out by Type, by Application?

This report presents a comprehensive overview of the global Cannabidiol (CBD) Distillate market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Full Spectrum
  • Broad Spectrum

Segment by Application

  • Dietary Supplements
  • Food and Beverages
  • E-cigarettes
  • Cosmetics
  • Pharmaceuticals

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Cannabidiol (CBD) Distillate market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Dietary Supplements, Food and Beverages, E-cigarettes evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Cannabidiol (CBD) Distillate Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 5.3%
Regional growth momentum
Market share by segment
Key metrics
Base value
$295
2025
Forecast
$423.5
2032
CAGR
5.3%
2025–2032
区域
5
global
Key companies
KeminPharma Works LLC (CanniLabs)SWISS ORGANIC PARTNERS AGKND LabsSequoyaEastern Spectrum GroupAlponics SASiam Herbal Tech
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Full SpectrumBroad Spectrum
By Application
Dietary SupplementsFood and BeveragesE-cigarettesCosmeticsPharmaceuticals

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Full Spectrum
  • 3.1.3 Broad Spectrum
  • 3.1.4 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Dietary Supplements
  • 4.1.3 Food and Beverages
  • 4.1.4 E-cigarettes
  • 4.1.5 Cosmetics
  • 4.1.6 Pharmaceuticals
  • 4.1.7 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Kemin
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Pharma Works LLC (CanniLabs)
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 SWISS ORGANIC PARTNERS AG
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 KND Labs
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Sequoya
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Eastern Spectrum Group
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Alponics SA
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Siam Herbal Tech
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 GVB Biopharma
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Mile High Labs
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 EcoGen Biosciences
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Ilesol Pharmaceuticals
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Red Mesa Science & Refining, LLC
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 WeeDutch
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 Essentia Pura
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 Blue Sky Hemp Ventures
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 Verus Extracts
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the current global Cannabidiol (CBD) Distillate market size?
The global Cannabidiol (CBD) Distillate market is estimated at US$ 295 million in 2025 (base year) and is projected to reach US$ 421 million by 2032.
What growth rate is expected for the Cannabidiol (CBD) Distillate market through 2032?
The market is expected to grow at a CAGR of 5.3% from 2026 to 2032, expanding from US$ 295 million in 2025 to US$ 421 million in 2032, roughly 1.4 times its base-year value.
How is Cannabidiol (CBD) Distillate defined?
CBD distillate is a highly purified form of cannabidiol that's been refined to remove impurities, specifically THC. That concentrated oil can then be used or combined with a full-spectrum CBD for an even more potent, impactful blend.CBD Distillate is a reduced version of the entire hemp plant with 50%-70% CBD content.
How is the Cannabidiol (CBD) Distillate market segmented by type?
By type, the market is segmented into Full Spectrum and Broad Spectrum.
What are the key applications of Cannabidiol (CBD) Distillate?
Key applications covered include Dietary Supplements, Food and Beverages, E-cigarettes, Cosmetics and Pharmaceuticals.
Which companies are profiled in the Cannabidiol (CBD) Distillate market report?
Key players profiled include Kemin, Pharma Works LLC (CanniLabs), SWISS ORGANIC PARTNERS AG, KND Labs, Sequoya, Eastern Spectrum Group, Alponics SA and Siam Herbal Tech, among 17 companies covered in total.
What geographies does the Cannabidiol (CBD) Distillate market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What are the key demand drivers for Cannabidiol (CBD) Distillate?
What factors are driving Cannabidiol (CBD) Distillate market growth, globally and by region?
Who should buy the Cannabidiol (CBD) Distillate market report?
The report is intended for manufacturers and solution providers, distributors and end users in Dietary Supplements, Food and Beverages and E-cigarettes, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Cannabidiol (CBD) Distillate market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

All data sources are cited within the report. View our full research methodology →
Select a license
from US$3,500.00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.